IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Inventiva S.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026
$2.98+0.04 (+1.36%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
87M
Shares held, 13F filers
Institutional holders
88
31 new, 7 sold out
Net institutional buying
37M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bvf Partners L P/Il | 8,545,499 | 6.10% | 13D (active) amendment | May 7, 2025 |
| Rick Yang | 8,350,730 | 6.00% | 13D (active) amendment | May 7, 2025 |
| Antoine Papiernik | 7,792,307 | 7.20% | 13G (passive) amendment | Dec 31, 2024 |
| Yiheng Capital, LLC | 7,597,148 | 5.46% | 13G (passive) amendment | Sep 30, 2025 |
| Siren, L.L.C. | 7,407,406 | 7.80% | 13G (passive) | Oct 17, 2024 |
| Francois Xavier Mauron | 6,148,147 | 6.50% | 13G (passive) | Oct 17, 2024 |
| Joseph Edelman | 5,555,555 | 5.80% | 13G (passive) | Dec 13, 2024 |
| Yuanshan Guo | 4,331,196 | 8.31% | 13G (passive) amendment | Sep 30, 2024 |
| Joseph Anderson | 19,086,050 | 8.60% | 13G (passive) amendment | Dec 31, 2025 |
| Raymond Debbane | 14,814,813 | 10.60% | 13G (passive) amendment | Jun 30, 2025 |
| Andera Partners | 14,114,476 | 7.70% | 13G (passive) amendment | Dec 31, 2025 |
| Srinivas Akkaraju | 13,540,194 | 7.40% | 13D (active) amendment | Nov 17, 2025 |
| David Kroin | 11,668,983 | 6.07% | 13G (passive) | Jan 23, 2026 |
| Dr. Jeffrey R. Jay, M.D. | 10,576,827 | 7.42% | 13G (passive) | May 5, 2025 |
| Finny Kuruvilla, M.D. Ph. D. | 10,118,517 | 6.70% | 13G (passive) | May 9, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Caligan Partners LP | 8,163,191 | – | $30.86M | +3,188,285 | 1.45% |
| Samsara BioCapital, LLC | 6,314,805 | – | $23.87M | +1,120,000 | 1.96% |
| Nantahala Capital Management, LLC | 5,372,786 | – | $20.31M | New | 0.34% |
| Paradigm Biocapital Advisors LP | 4,000,000 | – | $15.12M | – | 0.28% |
| Andera Partners | 3,633,181 | – | $13.73M | +1,815,000 | 6.65% |
| ADAR1 Capital Management, LLC | 3,606,656 | – | $13.63M | +1,432,258 | 0.62% |
| Millennium Management LLC | 3,512,174 | – | $13.28M | +524,561 | 0.00% |
| Trails Edge Capital Partners, LP | 2,657,997 | – | $10.05M | – | 1.60% |
| Franklin Resources Inc | 2,642,611 | – | $9.99M | +181,046 | 0.00% |
| Squadron Capital Management LLC | 2,435,000 | – | $9.20M | +1,900,000 | 2.86% |
| Woodline Partners LP | 2,323,149 | – | $8.78M | New | 0.03% |
| abrdn plc | 2,307,773 | – | $8.72M | New | 0.01% |
| UBS Group AG | 2,305,192 | – | $8.71M | −13,501 | 0.00% |
| Boothbay Fund Management, LLC | 2,003,782 | – | $7.57M | +533,375 | 0.10% |
| Patient Square Capital LP | 1,967,171 | – | $7.44M | New | 1.15% |
| NEXTBio Capital Management LP | 1,787,984 | – | $6.76M | +454,500 | 3.11% |
| Citadel Advisors LLC | 1,784,566 | – | $6.75M | +1,719,616 | 0.00% |
| Ameriprise Financial Inc | 1,697,148 | – | $6.42M | +852,933 | 0.00% |
| Point72 Asset Management, L.P. | 1,683,012 | – | $6.36M | +726,791 | 0.01% |
| Integral Health Asset Management, LLC | 1,520,000 | – | $5.75M | +1,120,000 | 0.23% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | 87M | 31 / 36 | 7 / 7 | 41M | 4M |
| Q1 2026 | 65 | 52M | 22 / 21 | 10 / 10 | 10M | 5M |
| Q4 2025 | 53 | 47M | 38 / 6 | 1 / 0 | 44M | 2M |
| Q3 2025 | 15 | 5M | 5 / 3 | 1 / 2 | 0M | 0M |
| Q2 2025 | 12 | 5M | 4 / 2 | 2 / 0 | 0M | 0M |
| Q1 2025 | 8 | 5M | 1 / 1 | 2 / 0 | 0M | 1M |
| Q4 2024 | 7 | 5M | 2 / 2 | 0 / 2 | 1M | 0M |
| Q3 2024 | 7 | 5M | 1 / 1 | 1 / 1 | 0M | 0M |
| Q2 2024 | 7 | 5M | 0 / 2 | 1 / 1 | 0M | 0M |
| Q1 2024 | 8 | 5M | 2 / 2 | 1 / 3 | 0M | 0M |
| Q4 2023 | 9 | 5M | 1 / 2 | 2 / 0 | 0M | 0M |
| Q3 2023 | 8 | 5M | 2 / 1 | 1 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IVA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | 1,014,919 | – | $4.55M | 0.39% | Jul 31, 2026 |
| Fidelity Advisor Biotechnology Fund | 685,400 | – | $3.07M | 0.14% | Jul 31, 2026 |
| Simplify Propel Opportunities ETF | 313,483 | – | $1.18M | 1.53% | Jun 30, 2026 |
| Fidelity Small Cap Stock Fund | 154,400 | – | $691.71K | 0.05% | Jul 31, 2026 |
| Artisan International Small-Mid Fund | 144,292 | – | $545.42K | 0.02% | Jun 30, 2026 |
| Fidelity Series Small Cap Core Fund | 136,161 | – | $610.00K | 0.04% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 42,752 | – | $161.60K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 34,355 | – | $169.37K | 0.00% | May 31, 2026 |
| Harbor Health Care ETF | 33,996 | – | $152.30K | 0.37% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 8,145 | – | $40.15K | 0.00% | May 31, 2026 |
| Fidelity Small Cap Stock K6 Fund | 2,400 | – | $10.75K | 0.05% | Jul 31, 2026 |